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Abstract Juvenile granulosa cell 
tumour (JGCT) is very uncommon 
gynecological malignancy that oc-
curs more commonly in under five 
years old of age. We describe a case 
of JGCT in a 4-years old girl. The 
malignancy is assigned to Interna-
tional Federation of Gynecology 
and Obstetric staging system (FIGO 
stage I). Treated with complete ex-
cision only, the patient showed no 
evidence of relapse one year after 
surgery.  
Findings in this case are discussed 
and histological examination con-
firmed the diagnosis. The natural 
history of JGCT, epidemiology, 
histology, treatment and prognosis 
are reviewed along with the case 
presentation. 
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Introduction 
 
Ovarian JGCT is extremely rare sex cord-stromal tu-
mour. 1 It comprises only 5% of ovarian tumours of 
childhood or adolescence. 2 Mohammed et al 3 from 
Zaria Northern Nigeria reported only two cases of JGCT 
among children 15 years and bellow in a 25 years re-
view of ovarian malignancies in childhood. Typically 
they present as sexual precocity in prepubertal girls due 
to excessive estrogen production. In some rare cases 
androgens may be produced. 2 JGCT is different from 
adult granulosa cell tumour (AGCT) that is seen in older 
females with respect to clinical and pathological features 
as well as biological behaviours. 4 Common symptoms 
include abdominal swelling, abnormal uterine bleeding, 
appearance of acne, breast enlargement and occasional 
facial hair appearance. There are no known risk factors 
for this tumour but recently, associations with changes 
in certain chromosomes were suspected. 5 Such changes 
include Gas-activating mutations in hot spots positi n 
201. Specifically, mutations R201C and R201H were 
exclusively localized in granulosa cell tumours. 6  
 
Juvenile granulosa cell tumour a subtype of ovarian stro-
mal cell tumours, has a favourable prognosis if diag-
nosed at early stage.  Recurrences are uncommon and 
typically occur within the first year.7 The incidence of 
this group of tumour is same throughout the world. 3, 8  
 
A more serious estrogen effects can occur in various end 
organs such as endometrial hyperplasia, endometrial 
adenocarcinomas and increased risk of breast cancers. 8 
Granulosa cell tumours can occur in the juvenile and 
adult male testes, though very rare.8 Majority of JGCT 
present as localized disease confined to the ovary, 9 and 
usually behave in a benign manner despite having histo-
pathological features of malignancy.4, 9  Conversely, 
advanced JGCT and poorly differentiated sertolic cell
tumours are considered prognostically poor.9 Histopa-
thologically, ovarian follicles are irregular in size and 
shape, leutenization occurs and the nuclei are immature, 
atypical and have ahigh mitotic rate. Exner bodies are 
classic features. These are grooved, pale and round n -
clei.10 A positive immunohistochemical stain for inhibin, 
an ovarian glycoprotein is a key diagnostic feature. 10  
 
Various modalities of treatment have been used ranging 
from surgical removal of the tumour to chemotherapy, 
radiotherapy and other treatments.5, 10 In adolescent girls 
and adult females, fertility sparing surgery can be done. 
Some have used platinum agent as standard treatment, 
either combined with Vinblastine and Bleomycine or 
Adriamycine and Cyclophosphomide.4, 5, 10  Other au-
thors now recommend the use of Bleomycin, Eptoposide 
and Platinum. Some studies suggested that patients aged 
19 years and below should have surgery and close moni-
toring for tumour recurrence only.4, 10 Others have used 
stem cell transplantation.5 Newer agents that block an-
giogenesis are being studied; two are being tried  
currently; sunitinib and bevacizumab.5 Hormone based 
treatments like paclitaxel and taxane in combination 
with platinum are also being advocated.10 The use of 
radiotherapy has not been shown to confer any survival 
benefit to JGCT at any stage. This case report is reported 
in a four year old girl to highlight clinical presentation, 
histologic characteristics of this rare tumor to remind 
clinicians the necessity to achieve correct diagnosis and 
proper selection of treatment protocol. 
 
Case report  
 
A four year old girl presented with a two month history 
of progressive abdominal swelling, one month history of 
fever and one week history of cough. There was associ-
ated progressive weight loss, no history suggestive of 
tuberculosis.  Painless breast enlargement preceded the 
abdominal swelling; there was an associated abdominal 
pains but no history of vaginal bleeding. Examination 
revealed bilateral breast enlargement (Fig 1a) and galac-
torrhoea in either breasts but no adrenarche or signifi-
cant peripheral lymphadenopathy.  
 
Fig 1a: Bilateral breast enlargement with galactorrhoea 













The abdomen was uniformly distended with firm multi-
lobulated masses with cystic areas and well defined up-
per border. There was no ascitis and her blood pressure 
was normal.  A clinical diagnosis of Wilms’ tumour was 
made with differential diagnoses of abdominal Burkitt 
lymphoma and abdominal tuberculosis. Investigation 
results showed a packed cell volume of 26% with pe-
ripheral leucocytosis of 15 X 109/L and neutrophilia of 
84%. Peripheral blood film showed toxic granulations: 
ESR was 50mm/hour and Mantoux test was negative. 
Serum electrolytes were within normal limits. Abdomi-
nal radiography showed no calcification. Abdominal 
ultrasound scan showed intraabdominal masses with 
multiple solid and cystic components but liver, spleen 
and kidneys were normal. Fine needle aspiration cytol-
ogy showed features suggestive of a round blue cell tu-
mour of childhood with possibilities of nephroblastoma, 
neuroblastoma and embryonal rhadomyosarcoma. The 
patient had exploratory laparatomy which showed huge 
left tubo-ovarian mass, cystic, multilobulated with well 
developed arterial supply from the surrounding caecum, 
transverse colon and the small intestine. The peritoneum 
was free: there was no ascites and o lymph node 
enlargement. The liver and spleen were normal.  
 
The patient was offered excisional biopsy of the tumo r 
(left oophrectomy). Histopathological report revealed an 
encapsulated partly cystic mass measuring 14 X 14 X 
9.5cm. The cut surface showed multilocular cyst con-
taining gelatinous materials as well as solid grey white 
areas.  Microscopically the solid section of the tumo r 
showed some neoplastic cells which were arranged in 
trabecular, insular, diffuse and microfollicular (Call-
Exner bodies) patterns separated by thin fibrous septae. 
The nuclei are relatively uniform with abundant cyto-
plasm. The tumor cells are lacking nuclei grooves 
(coffee-bean appearance). (Fig 1b) These features are 
consistent with JGCT. Patient did well postoperatively 
and regular follow-up for one year showed weight gain, 
regression of breast enlargement and no evidence of 
relapse. Patient was not on cytotoxic drugs or any other 
adjuvant therapy. 
 
Fig 1b: Photomicrograph of Juvenile granulosa cell tu-
mour lacking the “nuclei grooves” (coffee-bean appear-
















Sections from the ovarian mass show polygonal tumour cells 
arranged in trabecular, insular and microfollicular (Call-Exner 
bodies) patterns. The cells nuclei are relatively uniform with 
abundant cytoplasm. The tumour cells are lacking nuclei 




Granulosa cell tumours are rare sex cord stroma tumors; 
incidence varies from 1-5% of all ovarian tumours. 1, 2, 10 
A study in Zaria reported 2.1% prevalence of JGCT in 
children less than 16 years.3 These tumors are divided 
into JGCT and AGCT: JGCT often occurs within the 
first three years of life and cases have been reported 
even in a four months old baby.8, 9 The index patient 
presented at the age of four years which falls within the 
age at which JGCT presents in children.8, 9 She pre-
sented with abdominal swelling, breast enlargement, and 
abdominal pains these were consistent with various  
studies reported in the literature. 1, 10, 11  
 
Dysfunctional uterine bleeding and menstrual irregulari-
ties are frequently seen in women of reproductive age.10 
Thus it is not surprising that despite breast enlargement 
and galactorrhoea, the patient herein reported did not 
present with uterine bleeding. Rare cases of JGCT have 
been reported to secrete androgen causing virilization.10 
200 
Also, other cases have been associated with Maffuccis 
syndrome and enchondromatosis (Ollier’s disease).11 
The patient in our report had no evidence of virilization 
or any other associated condition.  Our patient wasin 
stage one disease as the tumor was well capsulated, re-
gional lymph nodes were normal and there was no peri-
toneal spill.10, 11 The histological report of this patient 
was consistent with JGCT, though immunohistochemi-
cal staining for inhibin and smooth muscle actin is po i-
tive in almost all cases.1, 10 These tests could not be done 
in our patient due to lack of reagents which could have 
given more distinctive findings of JGCT and also helps 
in monitoring for relapse. Computerized tomographic 
scan and magnetic resonance imaging could have been 
useful in diagnosis, but are v ry expensive.  
 
Some authorities advocate surgical therapy alone for 
stage one.1, 2, 4, 9 In fact others suggest that adjuvant che-
motherapy may not be necessary if the tumour can be 
excised completely.1 This is the treatment strategy 
adopted for our patient since she came in early stage one  
of the disease. Nevertheless, a v riety of chemothera-
peutic regimens have been suggested in the literatur .3, 4, 
9, 10-12 
These include; Cisplatin-based multi drug regimen  
effective in advanced stage of JGCT, Hormone based  
treatment with Pacilitaxel and Taxane in combination 
with Platinum based drugs. Some have used radiother-
apy as adjuvant treatment, but other authorities indicated 
that this does not have any advantage at all. 4, 10  
Stage one tumours carry favourable prognosis with five-
year survival between 95-100%. Resection of stage one-
tumour is considered to be curative. Our patient has
been followed up for one year now, and so far she i 
doing well. Relapse in JGCT usually occurs within the 
first year. 10 Some advocate follow-up to three y ars 10 
but recent reports have shown late recurrence of JGCT 
up to four years later.7 These suggest that long term sur-
veillance is highly necessary for this patient. Tumo r 
markers such as inhibin if possible should be used to 
assess recurrence in addition to other clinical and l bora-
tory investigations for patients.  
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